Advisory Research’s Alignment Healthcare ALHC Stock Holding History

Advisory Research’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-62,675	Closed	-$715K	–	354
2022 Q2	$715K	Buy	+62,675	New	+$661K	0.07%	188

Other funds holding ALHC

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Advisory Research's ALHC Position: Q3 2022 in Review

Advisory Research sold out of Alignment Healthcare (ALHC) in Q3 2022, closing a stake of 62,675 shares — an estimated $715K sold.

Advisory Research first reported a position in ALHC in Q2 2022 and held it in 1 quarter. The position peaked at $715K in Q2 2022. 150 funds tracked by Wall St. Rank hold ALHC as of Q3 2022.

Advisory Research reported no remaining Alignment Healthcare position as of Q3 2022 after selling out during the quarter.
Advisory Research sold 62,675 Alignment Healthcare shares in Q3 2022, an estimated $715K.
Advisory Research first reported a position in Alignment Healthcare in Q2 2022 and held it in 1 quarter.
Advisory Research's Alignment Healthcare position peaked at $715K in Q2 2022.
150 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2022.

Based on Advisory Research's 13F filing for Q3 2022, filed 15 Nov 2022.